|
|
| (15 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | {{pnc}} | | {{pnc}} |
| | + | {{ft|X}} |
| | *'''[[Diagnosis (Laboratory other parameters)]]''' | | *'''[[Diagnosis (Laboratory other parameters)]]''' |
| | + | *'''[[Dx multi-virus]]''' |
| | *'''[[Dx PCR]]''' | | *'''[[Dx PCR]]''' |
| | *'''[[Dx Antigen]]''' | | *'''[[Dx Antigen]]''' |
| | *'''[[Dx Antibodies]]''' | | *'''[[Dx Antibodies]]''' |
| − | *'''[[Dx various methods]]''' | + | *'''[[Dx Serology]]''' all the imbecile titles not showing what they intend to test |
| − | *''*[[Dx which matrix]] | + | *'''[[Dx Lab. various methods]]''' reviews, n>2 comparisons, intermodality comparisons |
| | + | *'''[[Dx Lab. unconventional methods]]''' |
| | + | *'''[[Dx which matrix]]''' how to obtain, which to use |
| | | | |
| − | '''Diagnosing Covid by pcr, antibodies and so on'''
| + | ---- |
| − | | + | |
| − | | + | |
| − | {{tp|p=32490723|t=2020. Development of a TaqMan-probe-based multiplex real-time PCR for the simultaneous detection of emerging and reemerging swine coronaviruses.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32428207|t=2020. Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32282894|t=ä. Diagnostic Testing for Severe Acute Respiratory Syndrome?Related Coronavirus-2: A Narrative Review |pdf=|usr=}}
| + | |
| − | *[https://archive.fo/61OpY on false-positives]
| + | |
| − | *[https://www.aljazeera.com/news/2020/05/tanzania-covid-19-lab-head-suspended-president-questions-data-200505065136872.html on positives in non-vertebrate samples]
| + | |
| − | *[https://www.wsj.com/articles/roche-coronavirus-antibody-test-wins-fda-approval-for-emergency-use-11588505019 antibody test roche]
| + | |
| − | {{tp|p=32293168|t=ä. Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor |pdf=|usr=}}
| + | |
| − | {{tp|p=32223179|t=ä. Diagnosing COVID-19: The Disease and Tools for Detection |pdf=|usr=}}
| + | |
| − | {{tp|p=32281785|t=ä. Dual-Functional Plasmonic Photothermal Biosensors for Highly Accurate Severe Acute Respiratory Syndrome Coronavirus 2 Detection |pdf=|usr=}}
| + | |
| − | {{tp|p=32320384|t=2020. Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32304208|t=ä. Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources |pdf=|usr=}}
| + | |
| − | {{tp|p=32227199|t=ä. SARS-CoV-2 Testing: Trials and Tribulations |pdf=|usr=}}
| + | |
| − | {{tp|p=32323974|t=ä. Rapid and Sensitive Detection of anti-SARS-CoV-2 IgG, Using Lanthanide-Doped Nanoparticles-Based Lateral Flow Immunoassay |pdf=|usr=}}
| + | |
| − | {{tp|p=Cä|t=Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea.|pdf=http://europepmc.org/articles/PMC7169629?pdf=render|usr=}}
| + | |
| − | {{tp|p=32259132|t=2020. Laboratory Parameters in Detection of COVID-19 Patients with Positive RT-PCR; a Diagnostic Accuracy Study |pdf=|usr=}}
| + | |
| − | {{tp|p=32331788|t=ä. Case-finding: Fast, Available, and Efficient Font-line Diagnostics for SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32290684|t=2020. Exhaled breath condensate as a potential specimen for diagnosing COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32364936|t=2020. Electrochemical biosensors for pathogen detection |pdf=|usr=}}
| + | |
| − | {{tp|p=32330437|t=ä. COVID-19: a meta-analysis of diagnostic test accuracy of commercial assays registered in Brazil |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32360478|t=2020. Emerging key laboratory tests for patients with COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32077933|t=ä. ...Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the Outbreak |pdf=|usr=}}
| + | |
| − | {{tp|p=32154877|t=ä. The SARS-CoV-2 Outbreak: Diagnosis, Infection Prevention, and Public Perception |pdf=|usr=}}
| + | |
| − | {{tp|p=32246822|t=ä. Potential false-negative nucleic acid testing results for Severe Acute Respiratory Syndrome Coronavirus 2 from thermal inactivation of samples with low viral loads |pdf=|usr=}}
| + | |
| − | {{tp|p=32353116|t=ä. Modeling SARS-CoV-2 positivity using laboratory data: timing is everything |pdf=|usr=}}
| + | |
| − | {{tp|p=32343775|t=ä. SARS-CoV-2 Serology: Much Hype, Little Data |pdf=|usr=}}
| + | |
| − | {{tp|p=32315390|t=ä. Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform |pdf=|usr=}}
| + | |
| − | {{tp|p=32282874|t=ä. Limits of Detection of Six Approved RT?PCR Kits for the Novel SARS-coronavirus-2 (SARS-CoV-2) |pdf=|usr=}}
| + | |
| − | {{tp|p=32031590|t=ä. Racing Towards the Development of Diagnostics for a Novel Coronavirus (2019-nCoV) |pdf=|usr=}}
| + | |
| − | {{tp|p=32229107|t=2020. Dynamic change process of target genes by RT-PCR testing of SARS-Cov-2 during the course of a Coronavirus Disease 2019 patient |pdf=|usr=}}
| + | |
| − | {{tp|p=32031583|t=ä. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia |pdf=|usr=}}
| + | |
| − | {{tp|p=32156607|t=ä. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020 |pdf=|usr=}}
| + | |
| − | {{tp|p=32343948|t=2020. IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study |pdf=|usr=}}
| + | |
| − | {{tp|p=32335089|t=ä. Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories |pdf=|usr=}}
| + | |
| − | {{tp|p=32315614|t=2020. Laboratory data analysis of novel coronavirus (COVID-19) screening in 2510 patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32295319|t=2020. Innovative screening tests for COVID-19 in South Korea |pdf=|usr=}}
| + | |
| − | {{tp|p=32358960|t=ä. Evaluation of COVID-19 RT-qPCR test in multi-sample pools |pdf=|usr=}}
| + | |
| − | {{tp|p=32357209|t=ä. Early detection of SARS-CoV-2 antibodies in COVID-19 patients as a serologic marker of infection |pdf=|usr=}}
| + | |
| − | {{tp|p=32357206|t=ä. Role of serology in the COVID-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32221523|t=ä. Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32221519|t=ä. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 |pdf=|usr=}}
| + | |
| − | {{tp|p=32047895|t=ä. Consistent Detection of 2019 Novel Coronavirus in Saliva |pdf=|usr=}}
| + | |
| − | {{tp|p=32271374|t=ä. Effect of throat washings on detection of 2019 novel coronavirus |pdf=|usr=}}
| + | |
| − | {{tp|p=32337590|t=ä. Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |pdf=|usr=}}
| + | |
| − | {{tp|p=32241023|t=ä. Gargle lavage as a safe and sensitive alternative to swab samples to diagnose COVID-19: a case report in Japan |pdf=|usr=}}
| + | |
| − | {{tp|p=32306047|t=ä. Antibody Detection and Dynamic Characteristics in Patients with COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32306042|t=ä. Testing for SARS-CoV-2: Can We Stop at Two?|pdf=|usr=}}
| + | |
| − | {{tp|p=32276116|t=ä. Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay |pdf=|usr=}}
| + | |
| − | {{tp|p=32306036|t=ä. Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19 patients |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32326952|t=2020. SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression |pdf=|usr=}}
| + | |
| − | {{tp|p=32313785|t=ä. A Review of Salivary Diagnostics and Its Potential Implication in Detection of Covid-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32295707|t=ä. Fast and simple high-throughput testing of COVID 19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32197339|t=2020. Point-of-Care RNA-Based Diagnostic Device for COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32260471|t=2020. In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends |pdf=|usr=}}
| + | |
| − | {{tp|p=32316113|t=2020. Combining Point-of-Care Diagnostics and Internet of Medical Things (IoMT) to Combat the COVID-19 Pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32244841|t=2020. Blockchain and Artificial Intelligence Technology for Novel Coronavirus Disease-19 Self-Testing |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32267220|t=2020. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32294051|t=2020. Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32273299|t=2020. Self-screening to reduce medical resource consumption facing the COVID-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32357808|t=2020. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32306864|t=2020. Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32196430|t=2020. Laboratory diagnosis of emerging human coronavirus infections - the state of the art |pdf=|usr=}}
| + | |
| − | {{tp|p=32207377|t=2020. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32306853|t=2020. Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32286155|t=2020. Significance of serology testing to assist timely diagnosis of SARS-CoV-2 infections: implication from a family cluster |pdf=|usr=}}
| + | |
| − | {{tp|p=32174267|t=2020. Era of molecular diagnosis for pathogen identification of unexplained pneumonia, lessons to be learned |pdf=|usr=}}
| + | |
| − | {{tp|p=32102625|t=2020. Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity |pdf=|usr=}}
| + | |
| − | {{tp|p=32065057|t=2020. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes |pdf=|usr=}}
| + | |
| − | {{tp|p=32020836|t=2020. RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32270412|t=ä. Ultrarapid diagnosis, microscope imaging, genome sequencing, and culture isolation of SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32342252|t=ä. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards |pdf=|usr=}}
| + | |
| − | {{tp|p=32329811|t=2020. The nucleic acid test of induced sputum should be used for estimation of patients cure with 2019-nCov |pdf=|usr=}}
| + | |
| − | {{tp|p=32156329|t=2020. Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system |pdf=|usr=}}
| + | |
| − | {{tp|p=32209163|t=2020. Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020 |pdf=|usr=}}
| + | |
| − | {{tp|p=32156330|t=2020. Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Bavaria, Germany, February 2020 |pdf=|usr=}}
| + | |
| − | {{tp|p=31992387|t=2020. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR |pdf=|usr=}}
| + | |
| − | {{tp|p=32046815|t=2020. Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020 |pdf=|usr=}}
| + | |
| − | {{tp|p=32347204|t=2020. Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020 |pdf=|usr=}}
| + | |
| − | {{tp|p=32290902|t=2020. An alternative workflow for molecular detection of SARS-CoV-2 escape from the NA extraction kit-shortage, Copenhagen, Denmark, March 2020 |pdf=|usr=}}
| + | |
| − | {{tp|p=32290904|t=2020. Roll-out of SARS-CoV-2 testing for healthcare workers at a large NHS Foundation Trust in the United Kingdom, March 2020 |pdf=|usr=}}
| + | |
| − | {{tp|p=32156101|t=2020. Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}}
| + | |
| − | {{tp|p=32297805|t=2020. Real-time RT-PCR in COVID-19 detection: issues affecting the results |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32377507|t=ä. A Cautionary Tale of False-Negative Nasopharyngeal COVID-19 Testing |pdf=|usr=}}
| + | |
| − | {{tp|p=32242876|t=2020. Development of in vitro transcribed RNA as positive control for laboratory diagnosis of SARS-CoV-2 in India |pdf=|usr=}}
| + | |
| − | {{tp|p=32342674|t=2020. Glove-Wall System for Respiratory Specimen Collection and COVID-19 Mass Screening |pdf=|usr=}}
| + | |
| − | {{tp|p=32363011|t=2020. Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32007627|t=2020. Novel coronavirus: From discovery to clinical diagnostics |pdf=|usr=}}
| + | |
| − | {{tp|p=32304994|t=ä. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32224986|t=2020. Human Saliva: Non-Invasive Fluid for Detecting Novel Coronavirus (2019-nCoV) |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32371192|t=ä. Using the diagnostic model based on routine laboratory tests to distinguish patients infected with SARS-CoV-2 from those infected with influenza virus |pdf=|usr=}}
| + | |
| − | {{tp|p=32251798|t=2020. Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019 |pdf=|usr=}}
| + | |
| − | {{tp|p=32344011|t=2020. Mild versus severe COVID-19: Laboratory markers |pdf=|usr=}}
| + | |
| − | {{tp|p=32315809|t=ä. Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously |pdf=|usr=}}
| + | |
| − | {{tp|p=32114193|t=2020. Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests |pdf=|usr=}}
| + | |
| − | {{tp|p=32370065|t=2020. Hybridization Chain Reactions Targeting the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) |pdf=|usr=}}
| + | |
| − | {{tp|p=32344568|t=2020. RT-qPCR Testing of SARS-CoV-2: A Primer |pdf=|usr=}}
| + | |
| − | {{tp|p=32276333|t=2020. Development of a Novel, Genome Subtraction-Derived, SARS-CoV-2-Specific COVID-19-nsp2 Real-Time RT-PCR Assay and Its Evaluation Using Clinical Specimens |pdf=|usr=}}
| + | |
| − | {{tp|p=32325642|t=2020. A Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32300101|t=2020. Saliva: potential diagnostic value and transmission of 2019-nCoV |pdf=|usr=}}
| + | |
| − | {{tp|p=32286019|t=2020. Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives |pdf=|usr=}}
| + | |
| − | {{tp|p=32269100|t=2020. Comparative Performance of SARS-CoV-2 Detection Assays using Seven Different Primer/Probe Sets and One Assay Kit |pdf=|usr=}}
| + | |
| − | {{tp|p=32350048|t=2020. Comparison of Commercially Available and Laboratory Developed Assays for in vitro Detection of SARS-CoV-2 in Clinical Laboratories |pdf=|usr=}}
| + | |
| − | {{tp|p=32350047|t=2020. The Role of Antibody Testing for SARS-CoV-2: Is There One?|pdf=|usr=}}
| + | |
| − | {{tp|p=32341143|t=2020. Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens |pdf=|usr=}}
| + | |
| − | {{tp|p=32341142|t=2020. Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the first rapid multiplex PCR commercial assay for SARS-CoV-2 detection |pdf=|usr=}}
| + | |
| − | {{tp|p=32341141|t=2020. Evaluation of Transport Media and Specimen Transport Conditions for the Detection of SARS-CoV-2 Using Real Time Reverse Transcription PCR |pdf=|usr=}}
| + | |
| − | {{tp|p=32332061|t=2020. Clinical Evaluation of Three Sample-To-Answer Platforms for the Detection of SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32327448|t=2020. Comparison of Abbott ID Now and Abbott m2000 methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from symptomatic patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32132196|t=2020. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens |pdf=|usr=}}
| + | |
| − | {{tp|p=32102856|t=2020. Negative Nasopharyngeal and Oropharyngeal Swabs Do Not Rule Out COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32317257|t=2020. Saliva as a non-invasive specimen for detection of SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32317256|t=2020. Validation of the Hologic s Aptima Unisex and Multitest Specimen collection kits used for Endocervical and Male Urethral Swab Specimen (Aptima Swab) for sample collection of SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32303565|t=2020. The Detection of SARS-CoV-2 using the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays |pdf=|usr=}}
| + | |
| − | {{tp|p=32303564|t=2020. Comparison of Abbott ID Now, Diasorin Simplexa, and CDC FDA EUA methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from individuals diagnosed with COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32295896|t=2020. Nasal swab sampling for SARS-CoV-2: A convenient alternative in time of nasopharyngeal swab shortage |pdf=|usr=}}
| + | |
| − | {{tp|p=32277023|t=2020. A method to prevent SARS-CoV-2 IgM false positives in gold immunochromatography and enzyme-linked immunosorbent assays |pdf=|usr=}}
| + | |
| − | {{tp|p=32277022|t=2020. Clinical evaluation of the cobas SARS-CoV-2 test and a diagnostic platform switch during 48 hours in the midst of the COVID-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32361322|t=2020. Interpret with caution: An evaluation of the commercial AusDiagnostics versus in-house developed assays for the detection of SARS-CoV-2 virus |pdf=|usr=}}
| + | |
| − | {{tp|p=32361324|t=ä. Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: a descriptive study |pdf=|usr=}}
| + | |
| − | {{tp|p=32302956|t=2020. Consistency analysis of COVID-19 nucleic acid tests and the changes of lung CT |pdf=|usr=}}
| + | |
| − | {{tp|p=32328218|t=ä. Salivary diagnostics in COVID-19: Future research implications |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32209385|t=ä. Profile of specific antibodies to SARS-CoV-2: The first report |pdf=|usr=}}
| + | |
| − | {{tp|p=32360885|t=ä. Value and Challenges: Nucleic Acid Amplification Tests for SARS?CoV-2 in Hospitalized COVID-19 Patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32335175|t=ä. Reliability and usefulness of a rapid IgM?IgG antibody test for the diagnosis of SARS-CoV-2 infection: a preliminary report |pdf=|usr=}}
| + | |
| − | {{tp|p=32335168|t=ä. Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32298676|t=ä. Saliva is a reliable tool to detect SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32031264|t=2020. Evolving status of the 2019 novel coronavirus infection: Proposal of conventional serologic assays for disease diagnosis and infection monitoring |pdf=|usr=}}
| + | |
| − | {{ttp|p=31944312|t=2020. Recent advances in the detection of respiratory virus infection in humans |pdf=|usr=}}
| + | |
| − | {{tp|p=32276051|t=ä. Development of Reverse Transcription Loop-Mediated Isothermal Amplification Assays Targeting SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32292623|t=2020. Recent advances and perspectives of nucleic acid detection for coronavirus |pdf=|usr=}}
| + | |
| − | {{tp|p=32159775|t=2020. Detection of SARS-CoV-2 in Different Types of Clinical Specimens |pdf=|usr=}}
| + | |
| − | {{tp|p=32250394|t=2020. Sample Pooling as a Strategy to Detect Community Transmission of SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32352933|t=2020. Characteristics and diagnosis rate of 5630 subjects receiving SARS-CoV-2 nucleic acid tests from Wuhan, China |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32074516|t=2020. Development of Genetic Diagnostic Methods for Novel Coronavirus 2019 (nCoV-2019) in Japan |pdf=|usr=}}
| + | |
| − | {{tp|p=32350226|t=2020. An assessment of real-time RT-PCR kits for SARS-CoV-2 detection |pdf=|usr=}}
| + | |
| − | {{tp|p=32266524|t=ä. A case report of COVID-19 with false negative RT-PCR test: necessity of chest CT |pdf=|usr=}}
| + | |
| − | {{tp|p=32207257|t=2020. A Patient with COVID-19 Presenting a False-Negative Reverse Transcriptase Polymerase Chain Reaction Result |pdf=|usr=}}
| + | |
| − | {{tp|p=32341519|t=ä. Retrospective analysis of laboratory testing in 54 patients with severe- or critical-type 2019 novel coronavirus pneumonia |pdf=|usr=}}
| + | |
| − | {{tp|p=32322891|t=ä. Double-Edged Spike?Are SARS-CoV-2 Serologic Tests Safe Right Now?|pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32224308|t=ä. Understanding COVID-19: what does viral RNA load really mean?|pdf=|usr=}}
| + | |
| − | {{tp|p=32342928|t=2020. Upper respiratory tract sampling in COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32342927|t=2020. Diagnostic performance of COVID-19 serology assays |pdf=|usr=}}
| + | |
| − | {{tp|p=32217609|t=2020. Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS?CoV-2/COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32361529|t=ä. Loop mediated isothermal amplification (LAMP) assays as a rapid diagnostic for COVID-19 |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32333644|t=2020. RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32183357|t=2020. 2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics |pdf=|usr=}}
| + | |
| − | {{tp|p=32106462|t=2020. Disposable DNA Amplification Chips with Integrated Low-Cost Heaters ? |pdf=|usr=}}
| + | |
| − | {{tp|p=32074444|t=2020. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=C7187661|t=ä. Group Testing for SARS-CoV-2: Forward to the Past?|pdf=|usr=}}
| + | |
| − | {{tp|p=32329979|t=2020. COVID-19 rapid antibody cassette point of care tests: practical considerations |pdf=|usr=}}
| + | |
| − | {{ttp|p=32358057|t=2020. Overcoming the bottleneck to widespread testing: A rapid review of nucleic acid testing approaches for COVID-19 detection |pdf=|usr=}}
| + | |
| − | {{ttp|p=32373393|t=ä. Rapid and Sensitive Detection of COVID-19 Using CRISPR/Cas12a-based Detection with Naked Eye Readout, CRISPR/Cas12a-NER |pdf=|usr=}}
| + | |
| − | {{tp|p=32270436|t=ä. Detection of serum IgM and IgG for COVID-19 diagnosis |pdf=|usr=}}
| + | |
| − | {{tp|p=32327566|t=2020. One ventilator for two patients: feasibility and considerations of a last resort solution in case of equipment shortage |pdf=|usr=}}
| + | |
| − | {{tp|p=32378843|t=2020. Akutt lungesviktsyndrom hos covid-19-pasient med negative nasofarynksprover |pdf=|usr=}}
| + | |
| − | {{tp|p=32311437|t=ä. Detection and analysis of nucleic acid in various biological samples of COVID-19 patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32283215|t=ä. False negative rate of COVID-19 is eliminated by using nasal swab test |pdf=|usr=}}
| + | |
| − | {{tp|p=32239445|t=ä. Development of a Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32293905|t=2020. SARS-CoV-2 Viral Load in Clinical Samples from Critically Ill Patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32338536|t=2020. A Bayesian analysis of strategies to rule out COVID19 using reverse transcriptase-polymerase chain reaction (RT-PCR) |pdf=|usr=}}
| + | |
| − | {{tp|p=32294808|t=2020. The Royal College of Pathologists of Australasia (RCPA) position statement on COVID-19 (serology) |pdf=|usr=}}
| + | |
| − | {{tp|p=32367615|t=2020. Trends and Innovations in Biosensors for COVID-19 Mass Testing |pdf=|usr=}}
| + | |
| − | {{ttp|p=32187837|t=2020. Supersensitive Multifluorophore RNA-FISH for Early Virus Detection and Flow-FISH by Using Click Chemistry |pdf=|usr=}}
| + | |
| − | {{ttp|p=32221132|t=2020. In Silico assessment of the impact of 2019 novel coronavirus (2019-nCoV) genomic variation on published real-time quantitative polymerase chain reaction detection assays |pdf=|usr=}}
| + | |
| − | {{tp|p=32149771|t=2020. A case of 2019 novel coronavirus infected pneumonia with twice negative 2019-nCoV nucleic acid testing within 8 days |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32191623|t=2020. The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks |pdf=|usr=}}
| + | |
| − | {{tp|p=32172228|t=2020. Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19) |pdf=|usr=}}
| + | |
| − | {{tp|p=32242831|t=2020. Clinical laboratory and SARS-CoV-2 infection: where do we stand?|pdf=|usr=}}
| + | |
| − | {{tp|p=32242829|t=2020. One disease, different features: COVID-19 laboratory and radiological findings in three Italian patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32301750|t=2020. Assessment of immune response to SARS-CoV-2 with fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays |pdf=|usr=}}
| + | |
| − | {{tp|p=32301749|t=2020. Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics |pdf=|usr=}}
| + | |
| − | {{tp|p=32301748|t=2020. Clinical chemistry tests for patients with COVID-19 - important caveats for interpretation |pdf=|usr=}}
| + | |
| − | {{tp|p=32301745|t=2020. Comparison of throat swabs and sputum specimens for viral nucleic acid detection in 52 cases of novel coronavirus (SARS-Cov-2)-infected pneumonia (COVID-19) |pdf=|usr=}}
| + | |
| − | {{tp|p=32286242|t=2020. The value of urine biochemical parameters in the prediction of the severity of coronavirus disease 2019 |pdf=|usr=}}
| + | |
| − | {{ttp|p=32378969|t=2020. Spectroscopy as a tool for detection and monitoring of Coronavirus (COVID-19) |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{ttp|p=32357381|t=2020. Respiratory sampling for severe acute respiratory syndrome coronavirus 2: An Overview |pdf=|usr=}}
| + | |
| − | {{tp|p=32329102|t=2020. Application of a portable instrument for rapid and reliable detection of SARS-CoV-2 infection in any environment |pdf=|usr=}}
| + | |
| − | {{tp|p=32295895|t=2020. Comparison of Copan ESwab and FLOQSwab for COVID-19 Diagnosis: Working around a Supply Shortage |pdf=|usr=}}
| + | |
| − | {{tp|p=32380382|t=ä. Detection of low levels of SARS-CoV-2 RNA from nasopharyngeal swabs using three commercial molecular assays |pdf=|usr=}}
| + | |
| − | {{ttp|p=32357377|t=2020. Performing the nasopharyngeal and oropharyngeal swab for 2019-novel coronavirus (SARS-CoV-2) safely: How to dress, undress, and technical notes |pdf=|usr=}}
| + | |
| − | {{ttp|p=32352180|t=2020. COVID-19: Nasal and oropharyngeal swab |pdf=|usr=}}
| + | |
| − | {{tp|p=32329138|t=2020. Who should perform the rhinopharyngeal swab in COVID-19 positive patients?|pdf=|usr=}}
| + | |
| − | {{tp|p=32356761|t=2020. Navigating the Pandemic Response Life Cycle: Molecular Diagnostics and Immunoassays in the Context of COVID-19 Management |pdf=|usr=}}
| + | |
| − | {{ttp|p=32311826|t=2020. COVID-19 and the clinical hematology laboratory |pdf=|usr=}}
| + | |
| − | {{ttp|p=32245835|t=2020. Laboratory Diagnosis of COVID-19: Current Issues and Challenges |pdf=|usr=}}
| + | |
| − | {{tp|p=32349033|t=2020. Novel biosensor platforms for the detection of coronavirus infection and SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32366669|t=2020. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test |pdf=|usr=}}
| + | |
| − | {{tp|p=32229605|t=2020. Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32227490|t=ä. Performance of VivaDiag COVID?19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID?19 in acute patients referring to emergency room department |pdf=|usr=}}
| + | |
| − | {{tp|p=32222993|t=ä. Genomic characterization and phylogenetic analysis of SARS?COV?2 in Italy |pdf=|usr=}}
| + | |
| − | {{tp|p=32104917|t=ä. Development and clinical application of a rapid IgM?IgG combined antibody test for SARS?CoV?2 infection diagnosis |pdf=|usr=}}
| + | |
| − | {{tp|p=32096564|t=ä. Combination of RT?qPCR testing and clinical features for diagnosis of COVID?19 facilitates management of SARS?CoV?2 outbreak |pdf=|usr=}}
| + | |
| − | {{tp|p=32243608|t=ä. Detection of antibodies against SARS?CoV?2 in patients with COVID?19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32270882|t=2020. False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence |pdf=|usr=}}
| + | |
| − | {{tp|p=32347966|t=2020. An Evolving Approach to the Laboratory Assessment of COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32330303|t=2020. Characteristics of patients with coronavirus disease (COVID-19) confirmed using an IgM-IgG antibody test |pdf=|usr=}}
| + | |
| − | {{tp|p=32330291|t=2020. Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience |pdf=|usr=}}
| + | |
| − | {{tp|p=32320064|t=2020. Evaluation of the auxiliary diagnostic value of antibody assays for the detection of novel coronavirus (SARS-CoV-2) |pdf=|usr=}}
| + | |
| − | {{tp|p=32311142|t=2020. Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China |pdf=|usr=}}
| + | |
| − | {{ttp|p=32297981|t=2020. COVID-19: Recommended sampling sites at different stage of the disease |pdf=|usr=}}
| + | |
| − | {{tp|p=32271278|t=2020. Integrated Radiologic Algorithm for COVID-19 Pandemic |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{ttp|p=32374370|t=2020. Interpreting Diagnostic Tests for SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32367861|t=2020. Bronchoalveolar specimen can help detect COVID-19 in suspicious case with negative PCR for nasopharyngeal specimen test |pdf=|usr=}}
| + | |
| − | {{tp|p=32301958|t=2020. The Promise and Peril of Antibody Testing for COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32236503|t=2020. Testing Individuals for Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}}
| + | |
| − | {{tp|p=32334422|t=2020. Smartphone-based multiplex 30-minute nucleic acid test of live virus from nasal swab extract |pdf=|usr=}}
| + | |
| − | {{tp|p=32247384|t=2020. Developing antibody tests for SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32171389|t=2020. SARS-CoV-2 RNA more readily detected in induced sputum than in throat swabs of convalescent COVID-19 patients |pdf=|usr=}}
| + | |
| − | {{ttp|p=32300245|t=2020. CRISPR-Cas12-based detection of SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32350462|t=2020. Antibody responses to SARS-CoV-2 in patients with COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32273607|t=2020. Virological assessment of SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32235945|t=2020. Virological assessment of hospitalized patients with COVID-2019 |pdf=|usr=}}
| + | |
| − | {{tp|p=32313159|t=2020. Will antibody tests for the coronavirus really change everything?|pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32311181|t=2020. SARS-CoV-2: What can saliva tell us?|pdf=|usr=}}
| + | |
| − | {{tp|p=32364358|t=2020. A specifikus IgM- es IgG-antitesteket detektalo gyorstesztek erteke a SARS CoV-2 virusfertozes kimutatasaban (A COVID-19-pandemia orvosszakmai kerdesei) |pdf=|usr=}}
| + | |
| − | {{tp|p=32302058|t=2020. Laboratory testing of SARS?CoV, MERS?CoV, and SARS?CoV?2 (2019?nCoV): Current status, challenges, and countermeasures |pdf=|usr=}}
| + | |
| − | {{tp|p=32179122|t=2020. Viral loads of SARS-CoV, MERS-CoV and SARS-CoV-2 in respiratory specimens: What have we learned?|pdf=|usr=}}
| + | |
| − | {{tp|p=32380210|t=ä. The Impacts of Viral Inactivating Methods On Quantitative RT-PCR for COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32302278|t=2020. The Appropriate Use of Testing for COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32223871|t=2020. Preliminary Results of Initial Testing for Coronavirus (COVID-19) in the Emergency Department |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=C7200353|t=2020. A nanoparticle pseudo pathogen for rapid detection and diagnosis of virus infection |pdf=|usr=}}
| + | |
| − | {{tp|p=C7169335|t=2020. Promising methods for detection of novel coronavirus SARS?CoV?2 |pdf=|usr=}}
| + | |
| − | {{tp|p=C7144506|t=2020. Technical guidance for laboratory testing of 2019-nCoV infection (Third Edition) |pdf=|usr=}}
| + | |
| − | {{tp|p=32382657|t=2020. Assay Techniques and Test Development for COVID-19 Diagnosis |pdf=|usr=}}
| + | |
| − | {{tp|p=32387093|t=2020. Distinct changes in the real-time PCR detectability of certain SARS-CoV-2 target sequences |pdf=|usr=}}
| + | |
| − | {{tp|p=32382418|t=2020. Detection of IgM and IgG antibodies in patients with coronavirus disease 2019 |pdf=|usr=}}
| + | |
| − | {{ttp|p=32313543|t=2018. Host Cell Mimic Polymersomes for Rapid Detection of Highly Pathogenic Influenza Virus via a Viral Fusion and Cell Entry Mechanism |pdf=|usr=}}
| + | |
| − | {{tp|p=32322898|t=ä. Double-Edged Spike: Are SARS-CoV-2 Serologic Tests Safe Right Now?|pdf=|usr=}}
| + | |
| − | {{ttp|p=22174638|t=2011. Applications of Next-Generation Sequencing Technologies to Diagnostic Virology |pdf=|usr=}}
| + | |
| − | {{tp|p=32378133|t=ä. Initial Observations with Molecular Testing for COVID-19 in a Private Hospital in Mumbai, India |pdf=|usr=}}
| + | |
| − | {{tp|p=C7184367|t=ä. COVID-19 in Pediatrics: A Laboratory Perspective |pdf=|usr=}}
| + | |
| − | {{tp|p=32389405|t=ä. Understanding Antibody Testing for COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32416598|t=2020. SARS-CoV-2 detection by direct rRT-PCR without RNA extraction |pdf=|usr=}}
| + | |
| − | {{tp|p=32403010|t=2020. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies |pdf=|usr=}}
| + | |
| − | {{tp|p=32388470|t=2020. Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa? COVID-19 direct assay |pdf=|usr=}}
| + | |
| − | {{tp|p=32403007|t=2020. Self-collection: An appropriate alternative during the SARS-CoV-2 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32403009|t=2020. Five-minute point-of-care testing for SARS-CoV-2: Not there yet |pdf=|usr=}}
| + | |
| − | {{tp|p=32403008|t=2020. A RT-PCR assay for the detection of coronaviruses from four genera |pdf=|usr=}}
| + | |
| − | {{tp|p=32388472|t=2020. The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan, China |pdf=|usr=}}
| + | |
| − | {{tp|p=32387968|t=2020. Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32416599|t=2020. Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG |pdf=|usr=}}
| + | |
| − | {{tp|p=32388471|t=2020. Clinical evaluation of a SARS-CoV-2 RT-PCR assay on a fully automated system for rapid on-demand testing in the hospital setting |pdf=|usr=}}
| + | |
| − | {{tp|p=32380382|t=2020. Detection of low levels of SARS-CoV-2 RNA from nasopharyngeal swabs using three commercial molecular assays |pdf=|usr=}}
| + | |
| − | {{tp|p=32388468|t=2020. Multi-Stage Group Testing Improves Efficiency of Large-Scale COVID-19 Screening |pdf=|usr=}}
| + | |
| − | {{tp|p=32389784|t=ä. Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32006218|t=ä. Clinical role of viral identification by a polymerase chain reaction-based diagnostic panel in adults hospitalized with community-acquired pneumonia |pdf=|usr=}}
| + | |
| − | {{tp|p=C7194818|t=ä. Pooling of samples for testing for SARS-CoV-2 in asymptomatic people |pdf=|usr=}}
| + | |
| − | {{tp|p=32466975|t=ä. Rapid immunoglobulin test confirms a suspected case of COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32248474|t=2020. Vergessen Sie die Schnellteste auf Coronavirus!|pdf=|usr=}}
| + | |
| − | {{tp|p=32342388|t=2020. Anwendung von Antikörper-Schnelltests ist Körperverletzung: Dr Matthias Orth |pdf=|usr=}}
| + | |
| − | {{tp|p=32372836|t=2020. The problems with so-called immunity tests |pdf=|usr=}}
| + | |
| − | {{tp|p=32376476|t=ä. Limited effectiveness of systematic screening by nasopharyngeal RT-PCR of medicalized nursing home staff after a first case of COVID-19 in a resident |pdf=|usr=}}
| + | |
| − | {{tp|p=C7197557|t=ä. Selecting a SARS-CoV-2/COVID molecular testing method for your laboratory |pdf=|usr=}}
| + | |
| − | {{tp|p=32380210|t=2020. The impacts of viral inactivating methods on quantitative RT-PCR for COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32330305|t=2020. SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens |pdf=|usr=}}
| + | |
| − | {{tp|p=32358955|t=ä. Still much to learn about the diagnostic role of SARS-CoV-2 antibody detection |pdf=|usr=}}
| + | |
| − | {{tp|p=32149770|t=2020. High-throughput sequencing for confirmation of suspected 2019-nCoV infection identified by fluorescence quantitative polymerase chain reaction |pdf=|usr=}}
| + | |
| − | {{tp|p=32198501|t=ä. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19) |pdf=|usr=}}
| + | |
| − | {{tp|p=32396505|t=2020. US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2.|pdf=|usr=007}}
| + | |
| − | | + | |
| − | {{tp|p=32459137|t=2020. Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32448084|t=2020. Analytical comparisons of SARS-COV-2 detection by qRT-PCR and ddPCR with multiple primer/probe sets.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32438868|t=2020. ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32419639|t=2020. Viral loads in throat and anal swabs in children infected with SARS-CoV-2.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32492721|t=2020. COVID-19 Pandemic and Role of Human Saliva as a Testing Biofluid in Point-of-Care Technology.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32505692|t=2020. Molecular analysis of several in-house rRT-PCR protocols for SARS-CoV-2 detection in the context of genetic variability of the virus in Colombia.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32492531|t=2020. Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples.|pdf=|usr=007}}
| + | |
| − | | + | |
| − | {{tp|p=32431052|t=2020. SARS-CoV-2 lgM/lgG antibody detection confirms the infection after three negative nucleic acid detection.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32443459|t=2020. Point-of-Care Diagnostic Tests for Detecting SARS-CoV-2 Antibodies: A Systematic Review and Meta-Analysis of Real-World Data.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32429101|t=2020. Use of Saliva for Diagnosis and Monitoring the SARS-CoV-2: A General Perspective.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32381641|t=2020. Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32404480|t=2020. Evaluation of a rapid diagnostic assay for detection of SARS CoV-2 antigen in nasopharyngeal swab.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32393482|t=2020. Open Development and Clinical Validation Of Multiple 3D-Printed Nasopharyngeal Collection Swabs: Rapid Resolution of a Critical COVID-19 Testing Bottleneck.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32505778|t=2020. Persistent detection of SARS-CoV-2 RNA in patients and healthcare workers with COVID-19.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32512376|t=2020. Evaluation of rapid diagnosis of novel coronavirus disease (COVID-19) using loop-mediated isothermal amplification.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32434706|t=2020. Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32505777|t=2020. Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32458479|t=2020. Diagnostic performance of immunochromatography assay for rapid detection of IgM and IgG in coronavirus disease 2019.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32342925|t=2020. Challenges of Covid-19 testing.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32491306|t=2020. The different tests for the diagnosis of COVID-19 - A review in Brazil so far.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32486477|t=2020. Development of a Portable, Ultra-Rapid and Ultra-Sensitive Cell-Based Biosensor for the Direct Detection of the SARS-CoV-2 S1 Spike Protein Antigen.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32459081|t=2020. Evaluacion de diferentes genes en la deteccion por RT-PCR del SARS-CoV-2 en muestras respiratorias y su evolucion en la infeccion.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32492294|t=2020. Swabs Collected by Patients or Health Care Workers for SARS-CoV-2 Testing.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32466536|t=2020. Graphene-Based Strategies in Liquid Biopsy and in Viral Diseases Diagnosis.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32395793|t=2020. SARS-CoV-2 infection virological diagnosis.|pdf=|usr=007}}
| + | |
| − | | + | |
| − | {{tp|p=32400235|t=2020. The role of lower respiratory tract samples in the diagnosis of COVID-19.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32329388|t=2020. Positive RT-PCR test results after consecutively negative results in patients with COVID-19.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32384820|t=2020. Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32466458|t=2020. Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32492760|t=2020. Diagnostic Performance of a Rapid Point of Care Test for SARS-CoV-2 in an Urban ED Setting.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32474555|t=2020. Evaluation of RdRp & ORF-1b-nsp14-based real-time RT-PCR assays for confirmation of SARS-CoV-2 infection: An observational study.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32456750|t=2020. Hospital infection and COVID-19: Do not put all your eggs on the "swab" tests.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32423519|t=2020. Screening for COVID-19: Patient Factors Predicting Positive PCR Test.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32321609|t=2020. Diagnostic Options for Coronavirus Disease 2019 (COVID-19).|pdf=|usr=007}}
| + | |
| − | {{tp|p=32449639|t=2020. SARS-CoV-2 RT-PCR: at least 2 viral targets are needed.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32420777|t=2020. Positive RT-PCR in urine from an asymptomatic patient with novel coronavirus 2019 infection: a case report.|pdf=|usr=007}}
| + | |
| − | {{ttp|p=32302471|t=2020. How to Obtain a Nasopharyngeal Swab Specimen.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32463086|t=2020. Clinical Utility of Buccal Swabs for Sars-Cov-2 Detection in Covid-19-Infected Children.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32510168|t=2020. Clinical performance of different SARS-CoV-2 IgG antibody tests.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32501535|t=2020. Identification of nsp1 gene as the target of SARS-CoV-2 real-time RT-PCR using nanopore whole genome sequencing.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32484950|t=2020. Amplification of human beta-glucuronidase gene for appraising the accuracy of negative SARS-CoV-2 RT-PCR results in upper respiratory tract specimens.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32484942|t=2020. Potential pitfalls of routine SARS-CoV-2 serology for mass screening.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32504946|t=2020. Validation and verification of the Abbott RealTime SARS-CoV-2 assay analytical and clinical performance.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32401064|t=2020. CRISPR-cas systems based molecular diagnostic tool for infectious diseases and emerging 2019 novel coronavirus (COVID-19) pneumonia.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32504735|t=2020. Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32442248|t=2020. Testing for Novel Covid-19 antibodies: a necessary adjunct.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32427340|t=2020. Influence of storage conditions on SARS-CoV-2 nucleic acid detection in throat swabs.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32427334|t=2020. Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32397487|t=2020. Saliva-Friend and Foe in the COVID-19 Outbreak.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32475012|t=2020. Testing for SARS-CoV-2: the day the world turned its attention to the clinical laboratory.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32511679|t=2020. The Laboratory Diagnosis of COVID-19-- Frequently-Asked Questions.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32506118|t=2020. Occurrence and Timing of Subsequent SARS-CoV-2 RT-PCR Positivity Among Initially Negative Patients.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32504529|t=2020. Can the SARS-CoV-2 PCR Cycle Threshold Value and Time from Symptom Onset to Testing Predict Infectivity?|pdf=|usr=007}}
| + | |
| − | {{tp|p=32437513|t=2020. Molecular and serological assays for SARS-CoV-2: insights from genome and clinical characteristics.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32484887|t=2020. Clinical performance of the Elecsys electrochemiluminescent immunoassay for the detection of SARS-CoV-2 total antibodies.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32484860|t=2020. Clinical Performance of the Roche SARS-CoV-2 Serologic Assay.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32386187|t=2020. Antibody tests for COVID-19: drawing attention to the importance of analytical specificity.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32459192|t=2020. Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32459191|t=2020. Diagnostic performance of a SARS-CoV-2 IgG/IgM lateral flow immunochromatography assay in symptomatic patients presenting to the emergency department.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32447328|t=2020. Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32472684|t=2020. Seroconversion rate and diagnostic accuracy of serological tests for COVID-19.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32472672|t=2020. What is the role of SARS-CoV-2 PCR testing in discontinuation of transmission-based precautions for COVID-19 patients?|pdf=|usr=007}}
| + | |
| − | {{tp|p=32445559|t=2020. Whole nucleocapsid protein of SARS-CoV-2 may cause false positive results in serological assays.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32442256|t=2020. Predicting infectious SARS-CoV-2 from diagnostic samples.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32435816|t=2020. To Interpret the SARS-CoV-2 Test, Consider the Cycle Threshold Value.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32320539|t=2020. La Asociacion Catalana de Salud Laboral (@SCSL) ante el gran reto de la COVID-19.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32510339|t=2020. Homogeneous circle-to-circle amplification for real-time optomagnetic detection of SARS-CoV-2 RdRp coding sequence.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32439655|t=2020. Covid-19: Two antibody tests are "highly specific" but vary in sensitivity, evaluations find.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32398230|t=2020. Interpreting a covid-19 test result.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32349966|t=2020. Covid-19: Antibody test that claims to be 99% accurate is certified by EU.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32385433|t=2020. Saliva testing for COVID-19?|pdf=|usr=007}}
| + | |
| − | {{tp|p=32472673|t=2020. Cohort PCR Testing: A Strategic Method for Rapid SARS-CoV-2 Screening.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32462195|t=2020. Clinical Evaluation and Utilization of Multiple Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32401598|t=2020. COVID-19 Real-time RTPCR: Does Positivity on Follow up RTPCR Always Imply Infectivity?|pdf=|usr=007}}
| + | |
| − | {{tp|p=32401535|t=2020. Reply to: COVID-19 Real-time RTPCR: Does Positivity on Follow up RTPCR Always Imply Infectivity?|pdf=|usr=007}}
| + | |
| − | {{tp|p=32420937|t=2020. Current laboratory diagnostics of coronavirus disease 2019 (COVID-19).|pdf=|usr=007}}
| + | |
| − | {{tp|p=32420926|t=2020. Point-of-Care diagnostic of SARS-CoV-2: knowledge, attitudes, and perceptions (KAP) of medical workforce in Italy.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32506693|t=2020. Diagnosis of COVID-19 infection in children: less nasopharyngeal swabs, more saliva.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32501019|t=2020. 'Self-collected upper respiratory tract swabs for COVID-19 test': A feasible way to increase overall testing rate and conserve resources in South Africa.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32482077|t=2020. Biosensors for Managing the COVID-19 Cytokine Storm: Challenges Ahead.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32455796|t=2020. Optimization of the CDC Protocol of Molecular Diagnosis of COVID-19 for Timely Diagnosis.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32438677|t=2020. Antibody Tests in Detecting SARS-CoV-2 Infection: A Meta-Analysis.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32434807|t=2020. COVID-19 serologic testing: FAQs and caveats.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32505774|t=2020. SARS-CoV-2 antibody characterization in emergency department, hospitalized and convalescent patients by two semi-quantitative immunoassays.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32456766|t=2020. Are patients with systemic lupus erythematosus more prone to result false-positive for SARS-CoV2 serology?|pdf=|usr=007}}
| + | |
| − | {{tp|p=32508026|t=2020. A new and rapid approach for detecting COVID-19 based on S1 protein fragments.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32501021|t=2020. Community-based screening and testing for Coronavirus in Cape Town, South Africa: Short report.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32510340|t=2020. Diagnostic methods and potential portable biosensors for coronavirus disease 2019.|pdf=|usr=007}}
| + | |
| − | {{ttp|p=32450754|t=2020. Inappropriate Nasopharyngeal Sampling for SARS-CoV-2 Detection Is a Relevant Cause of False-Negative Reports.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32407189|t=2020. Recommendation of fecal specimen for routine molecular detection of SARS-CoV-2 and for COVID-19 discharge criteria.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32294815|t=2020. [Clinical observation on increasing the positive rate of novel coronavirus nucleic acid tests by sputum excretion induced by nebulizer therapy].|pdf=|usr=007}}
| + | |
| − | {{tp|p=32398876|t=2020. A serological assay to detect SARS-CoV-2 seroconversion in humans.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32385368|t=2020. First CRISPR test for the coronavirus approved in the United States.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32407257|t=2020. Assessing the Value of Diagnostic Tests in the New World of COVID-19 Pandemic.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32493981|t=2020. The COVID-19 testing debacle.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32358105|t=2020. Sniffing out Covid-19.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32270938|t=2020. Performance du frottis nasopharynge-PCR pour le diagnostic du Covid-19 - Recommandations pratiques sur la base des premieres donnees scientifiques.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32430309|t=2020. Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32493791|t=2020. COVID-19 diagnostics in context.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32439785|t=2020. COVID-19 spotlights medical diagnostics.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32414781|t=2020. Serology assays to manage COVID-19.|pdf=|usr=007}}
| + | |
| − | | + | |
| − | {{tp|p=32473021|t=2020. Performance of SARS-CoV-2 antibody assays in different stages of the infection: Comparison of commercial ELISA and rapid tests.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32229604|t=2020. Evaluation of Saline, Phosphate-Buffered Saline, and Minimum Essential Medium as Potential Alternatives to Viral Transport Media for SARS-CoV-2 Testing.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32483586|t=2020. Clinical Validation of a SARS-CoV-2 Real-Time Reverse Transcription PCR Assay Targeting the Nucleocapsid Gene.|pdf=|usr=007}}
| + | |
| − | | + | |
| − | | + | |
| − | {{ttp|p=32404473|t=2020. Towards effective diagnostic assays for COVID-19: a review.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32198190|t=2020. Practical laboratory considerations amidst the COVID-19 outbreak: early experience from Singapore.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32435872|t=2020. Lab-on-a-Chip Devices for Point-of-Care Medical Diagnostics.|pdf=|usr=007}}
| + | |
| − | | + | |
| − | {{tp|p=32461288|t=2020. Patients with Common Cold Coronaviruses Tested Negative for IgG Antibody to SARS-CoV-2.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32461287|t=2020. Comparison of two commercial molecular tests and a laboratory-developed modification of the CDC 2019-nCoV RT-PCR assay for the detection of SARS-CoV-2.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32461285|t=2020. Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32444354|t=2020. Test Agreement Between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32414839|t=2020. Stability of SARS-CoV-2 in PBS for Molecular Detection.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32414838|t=2020. Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32404481|t=2020. Large-scale, in-house production of viral transport media to support SARS-CoV-2 PCR testing in a multi-hospital healthcare network during the COVID-19 pandemic.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32503847|t=2020. Multi-Center Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Assay for the Detection of SARS-CoV-2 in Oropharyngeal Swab Specimens.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32482633|t=2020. Clinical performance of the Luminex NxTAG CoV Extended Panel for SARS-CoV-2 detection in nasopharyngeal specimens of COVID-19 patients in Hong Kong.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32381643|t=2020. Comparison of Two High-Throughput Reverse Transcription-Polymerase Chain Reaction Systems for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32381642|t=2020. Understanding, verifying and implementing Emergency Use Authorization molecular diagnostics for the detection of SARS-CoV-2 RNA.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32471894|t=2020. Performance of Abbott ID NOW COVID-19 rapid nucleic acid amplification test in nasopharyngeal swabs transported in viral media and dry nasal swabs, in a New York City academic institution.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32467359|t=2020. Influence of Different Inactivation Methods on Severe Acute Respiratory Syndrome Coronavirus 2 RNA Copy Number.|pdf=|usr=007}}
| + | |
| − | {{ttp|p=32502333|t=2020. Practical Guidelines for Collection, Manipulation and Inactivation of SARS-CoV-2 and COVID-19 Clinical Specimens.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32475066|t=2020. Two Detailed Plaque Assay Protocols for the Quantification of Infectious SARS-CoV-2.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32361691|t=2020. Molecular diagnostics at the times of SARS-CoV-2 outbreak.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32462501|t=2020. The Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 infection diagnosis?|pdf=|usr=0
| + | |
| − | {{tp|p=32500987|t=2020. Characteristics and assessment of the usefulness of serological tests in the diagnostic of infections caused by coronavirus SARS-CoV-2 on the basis of available manufacturer's data and literature review.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32467977|t=2020. Challenges of community point-of-care antibody testing for COVID-19 herd-immunity in Japan.|pdf=|usr=007}}
| + | |
| − | | + | |
| − | ===008===
| + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32437124|t=2020. Selective Naked-Eye Detection of SARS-CoV-2 Mediated by N Gene Targeted Antisense Oligonucleotide Capped Plasmonic Nanoparticles.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32469511|t=2020. Virus Detection: What Were We Doing before COVID-19 Changed the World?|pdf=|usr=008}}
| + | |
| − | | + | |
| − | {{tp|p=32528710|t=2020. Persistence of positive severe acute respiratory syndrome coronavirus-2 reverse transcription-polymerase chain reaction test result for 24 days in a hospitalized asymptomatic carrier.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | {{tp|p=32412044|t=2020. Antibody Testing for COVID-19.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32487335|t=2020. Nasopharyngeal swab collection in the suspicion of Covid-19.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32427600|t=2020. Interpreting the COVID-19 Test Results: A Guide for Physiatrists.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32355546|t=2020. Clinical evaluation of a rapid colloidal gold immunochromatography assay for SARS-Cov-2 IgM/IgG.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | {{tp|p=32438806|t=2020. Novel One-Step Single-Tube Nested Quantitative Real-Time PCR Assay for Highly Sensitive Detection of SARS-CoV-2.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32427657|t=2020. Can pediatric COVID-19 testing sensitivity be improved with sequential tests?|pdf=|usr=008}}
| + | |
| − | {{tp|p=32496919|t=2020. Serodiagnostics for Severe Acute Respiratory Syndrome-Related Coronavirus-2: A Narrative Review.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32331789|t=2020. Global Threat of SARS-CoV-2/COVID-19 and the Need for More and Better Diagnostic Tools.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | {{tp|p=32453605|t=2020. Rapid and robust bioanalytical assays are critical for SARS-CoV-2 therapeutic and vaccine development and beyond.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32395391|t=2020. Development of a rapid test kit for SARS-CoV-2: an example of product design.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32419272|t=2020. Molecular Targets for the Testing of COVID-19.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32406424|t=2020. Covid-19: Why test? Who to test? How to test?|pdf=|usr=008}}
| + | |
| − | {{tp|p=32533461|t=2020. Positive tracheal SARS-CoV-2 RNA test after three negative SARS-CoV-2 RNA tests in a patient with COVID-19.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32387502|t=2020. Reduced Physical Activity During COVID-19 Pandemic in Children With Congenital Heart Disease.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | {{tp|p=32427226|t=2020. An automated Residual Exemplar Local Binary Pattern and iterative ReliefF based corona detection method using lung X-ray image.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32534909|t=2020. First detection of SARS-CoV-2 by real-time reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay in pleural fluid.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32518132|t=2020. Operationalizing COVID-19 testing: Who, what, when, where, why, and how.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32384153|t=2020. Rapid detection of SARS-CoV-2 by low volume real-time single tube reverse transcription recombinase polymerase amplification using an exo probe with an internally linked quencher (exo-IQ).|pdf=|usr=008}}
| + | |
| − | {{tp|p=32402061|t=2020. Clinical Performance of Two SARS-CoV-2 Serologic Assays.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32485157|t=2020. Diagnostic performances and thresholds: The key to harmonization in serological SARS-CoV-2 assays?|pdf=|usr=008}}
| + | |
| − | {{tp|p=32485155|t=2020. Comparison of the Elecsys(R) Anti-SARS-CoV-2 immunoassay with the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32526218|t=2020. Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32473953|t=2020. Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32422410|t=2020. Multiple-centre clinical evaluation of an ultrafast single-tube assay for SARS-CoV-2 RNA.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32422408|t=2020. Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32531475|t=2020. Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32502646|t=2020. Comparison of diagnostic accuracies of rapid serological tests and ELISA to molecular diagnostics in patients with suspected coronavirus disease 2019 presenting to the hospital.|pdf=|usr=008
| + | |
| − | {{tp|p=32520228|t=2020. Sensitivity of the Wondfo One Step COVID-19 test using serum samples.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32444479|t=2020. Incidental COVID-19 on PET/CT imaging.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32493742|t=2020. Diagnostic testing for SARS-CoV-2.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32483515|t=2020. What Do We Need to Know to Improve Diagnostic Testing Methods for the 2019 Novel Coronavirus?|pdf=|usr=008}}
| + | |
| − | | + | |
| − | {{tp|p=32302069|t=2020. SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32386354|t=2020. Can dried blood spots (DBS) contribute to conducting comprehensive SARS-CoV-2 antibody tests?|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32383097|t=2020. Nasopharyngeal swabs during SARS-CoV-2 pandemic: a role for the otolaryngologist.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32530490|t=2020. A Simple Method for Detection of a Novel Coronavirus (SARS-CoV-2) using One-step RT-PCR followed by Restriction Fragment Length Polymorphism.|pdf=|usr=008}}
| + | |
| − | {{ttp|p=32535768|t=2020. COVID-19: molecular diagnostics overview.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32441935|t=2020. A Reverse-Transcription Recombinase-Aided Amplification Assay for Rapid Detection of the 2019 Novel Coronavirus (SARS-CoV-2).|pdf=|usr=008}}
| + | |
| − | {{tp|p=32490854|t=2020. A novel liquid biopsy-based approach for highly specific cancer diagnostics: mitigating false responses in assaying patient plasma-derived circulating microRNAs through combined SERS and plasmon-enhanced fluorescence analyses.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32343598|t=2020. Serological tests for COVID-19 antibodies: Limitations must be recognized.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | {{tp|p=32487681|t=2020. SARS-CoV-2 serology: Test, test, test, but interpret with caution!|pdf=|usr=008}}
| + | |
| − | {{tp|p=32515793|t=2020. Why, when, and how to use lung ultrasound during the COVID-19 pandemic: enthusiasm and caution.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32527161|t=2020. How Fear Appeal Approaches in COVID-19 Health Communication May Be Harming the Global Community.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32533803|t=2020. The Covid-19 'infodemic': a new front for information professionals.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32522311|t=2020. RT-PCR tests for SARS-CoV-2 processed at a large Italian Hospital and false-negative results among confirmed COVID-19 cases.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32530790|t=2020. Ellen Grass Lecture: Wellness for Allied Healthcare Professionals in the Age of COVID-19.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32489177|t=2020. Authors' response: SARS-CoV-2 detection by real-time RT-PCR.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32489175|t=2020. Letter to the editor: SARS-CoV-2 detection by real-time RT-PCR.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32400364|t=2020. Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32411619|t=2020. Current and Future Point-of-Care Tests for Emerging and New Respiratory Viruses and Future Perspectives.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32391022|t=2020. Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | {{tp|p=32452225|t=2020. Nasopharyngeal swab or clinical-radiological evidence: the dark side of the moon for cancer patients in the COVID-19 era.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32432217|t=2020. COVID-19 Special Column: Principles Behind the Technology for Detecting SARS-CoV-2, the Cause of COVID-19.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32389155|t=2020. Utility of retesting for diagnosis of SARS-CoV-2/COVID-19 in hospitalized patients: Impact of the interval between tests.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32389132|t=2020. Pharynx gargle samples are suitable for SARS-CoV-2 diagnostic use and save personal protective equipment and swabs.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | {{tp|p=32532934|t=2020. COVID 19 diagnostic multiplicity and its role in community surveillance and control.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | {{tp|p=32344452|t=2020. Rapid detection of SARS-CoV-2 in saliva: can an endodontist take the lead in point-of-care COVID-19 testing?|pdf=|usr=008}}
| + | |
| − | | + | |
| − | {{tp|p=32417248|t=2020. SARS-CoV-2 infection diagnosed only by cell culture isolation before the local outbreak in an Italian seven-week-old suckling baby.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32518072|t=2020. Culture-based virus isolation to evaluate potential infectivity of clinical specimens tested for COVID-19.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32522596|t=2020. Recent Advances in Molecular diagnosis curbing the COVID-19.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32535302|t=2020. Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32497809|t=2020. Evaluation of novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32479758|t=2020. SARS-CoV-2 Antibody Testing - Questions to be asked.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32445839|t=2020. Clinical Testing For Covid-19.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32531884|t=2020. The Enemy Which Sealed the World: Effects of COVID-19 Diffusion on the Psychological State of the Italian Population.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32098019|t=2020. Communicating the Risk of Death from Novel Coronavirus Disease (COVID-19).|pdf=|usr=008}}
| + | |
| − | | + | |
| − | {{tp|p=32281158|t=2020. The pandemic paradox: The consequences of COVID-19 on domestic violence.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32344460|t=2020. The potential for COVID-19 to contribute to compassion fatigue in critical care nurses.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32320509|t=2020. Covid-19: Supporting nurses' psychological and mental health.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32535398|t=2020. Comparison of a laboratory-developed test targeting the envelope gene with three nucleic acid amplification tests for detection of SARS-CoV-2.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32504944|t=2020. Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods: Experiences of a general hospital.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32516739|t=2020. Evaluation of the commercially available LightMix(R) Modular E-gene kit using clinical and proficiency testing specimens for SARS-CoV-2 detection.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32504945|t=2020. Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: A prospective single-center study.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32485620|t=2020. Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32485618|t=2020. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32504943|t=2020. The utility of beta-2-microglobulin testing as a human cellular control in COVID-19 testing.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32425660|t=2020. A combined oropharyngeal/nares swab is a suitable alternative to nasopharyngeal swabs for the detection of SARS-CoV-2.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32535397|t=2020. Multiplexing primer/probe sets for detection of SARS-CoV-2 by qRT-PCR.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32526675|t=2020. AusDiagnostics SARS-CoV-2 kits shown to be more sensitive than reference laboratory test.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32361285|t=2020. Comparing the analytical performance of three SARS-CoV-2 molecular diagnostic assays.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32353760|t=2020. Comparison of the Panther Fusion and a laboratory-developed test targeting the envelope gene for detection of SARS-CoV-2.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32344319|t=2020. Ad hoc laboratory-based surveillance of SARS-CoV-2 by real-time RT-PCR using minipools of RNA prepared from routine respiratory samples.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32485473|t=2020. Evaluation of nCoV-QS (MiCo BioMed) for RT-qPCR detection of SARS-CoV-2 from nasopharyngeal samples using CDC FDA EUA qPCR kit as a gold standard: An example of the need of validation studies.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32474371|t=2020. Rapid implementation and validation of a cold-chain free SARS-CoV-2 diagnostic testing workflow to support surge capacity.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32460173|t=2020. Clinical evaluation of AusDiagnostics SARS-CoV-2 multiplex tandem PCR assay.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32425657|t=2020. Evaluation of the COVID19 ID NOW EUA assay.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32417674|t=2020. Multi-center evaluation of cepheid xpert(R) xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32416600|t=2020. Comparison of seven commercial RT-PCR diagnostic kits for COVID-19.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32405257|t=2020. Validation of SARS-CoV-2 detection across multiple specimen types.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32405254|t=2020. Real-time PCR-based SARS-CoV-2 detection in Canadian laboratories.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32143123|t=2020. Rapid random access detection of the novel SARS-coronavirus-2 (SARS-CoV-2, previously 2019-nCoV) using an open access protocol for the Panther Fusion.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32381379|t=2020. Saliva samples as an alternative for novel coronavirus (COVID-19) diagnosis.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32446722|t=2020. Evaluation of a high-speed but low-throughput RT-qPCR system for SARS-CoV-2 detection.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32173458|t=2020. Experience of different upper respiratory tract sampling strategies for detection of COVID-19.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32474037|t=2020. Improved sensitivity using a dual target, E and RdRp assay for the diagnosis of SARS-CoV-2 infection: Experience at a large NHS Foundation Trust in the UK.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32474036|t=2020. Qualitative serology in patients recovered from SARS CoV 2 infection.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32473233|t=2020. Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32473229|t=2020. Follow-up study on pulmonary function and radiological changes in critically ill patients with COVID-19.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32504740|t=2020. Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32283141|t=2020. Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | {{tp|p=32382737|t=2020. A Peptide-based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019 (COVID-19).|pdf=|usr=008}}
| + | |
| − | {{tp|p=32534946|t=2020. Laboratory diagnosis of SARS-CoV-2 - A review of current methods.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32449329|t=2020. Clinical Significance of a High SARS-CoV-2 Viral Load in the Saliva.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | {{tp|p=32383182|t=2020. Should RT-PCR be considered a gold standard in the diagnosis of Covid-19?|pdf=|usr=008}}
| + | |
| − | {{tp|p=32383179|t=2020. Comparison of SARS-CoV-2 detection from nasopharyngeal swab samples by the Roche cobas 6800 SARS-CoV-2 test and a laboratory-developed real-time RT-PCR test.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32369202|t=2020. Pooling of nasopharyngeal swab specimens for SARS-CoV-2 detection by RT-PCR.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32401374|t=2020. Prolonged SARS-Cov-2 RNA Detection in Anal/Rectal Swabs and Stool Specimens in COVID-19 Patients After Negative Conversion in Nasopharyngeal RT-PCR Test.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32401343|t=2020. Evaluating the efficiency of specimen pooling for PCR-based detection of COVID-19.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32219885|t=2020. Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32330297|t=2020. Optimization of group size in pool testing strategy for SARS-CoV-2: A simple mathematical model.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32513617|t=2020. In vitro diagnostics of coronavirus disease 2019: Technologies and application.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32405270|t=2020. Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Is Comparable in Clinical Samples Preserved in Saline or Viral Transport Medium.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32501315|t=2020. Au-decorated BN nanotube as a breathalyzer for potential medical applications.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32496708|t=2020. COVID-19 : quelle place, aujourd'hui, pour les tests serologiques ?|pdf=|usr=008}}
| + | |
| − | {{tp|p=32536002|t=2020. Pitfalls in SARS-CoV-2 PCR diagnostics.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32526372|t=2020. Establishing a model for predicting the outcome of COVID-19 based on combination of laboratory tests.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32166939|t=2020. [Which sampling method for the upper respiratory tract specimen should be taken to diagnose patient with COVID-19?]|pdf=|usr=008}}
| + | |
